Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Coronavirus channel feed
Covid-19 roundup: Ugur Sahin says new shots likely needed for Omicron; UK fully approves Vir/GlaxoSmithKline antibody
4 years ago
British CDMO Sterling partners up on low-cost manufacturing of molnupiravir
4 years ago
Manufacturing
Samsung Biologics takes on manufacturing duties for GreenLight's Covid-19 vaccine
4 years ago
Manufacturing
Covid-19 manufacturing roundup: 3 companies to collaborate on mRNA vaccine; Omicron-focused vaccine could be on the way
4 years ago
Manufacturing
As Omicron spread looms, oral antivirals appear to be one of the best defenses — now we just need more
4 years ago
Pharma
As first Omicron case in US crops up, researchers wonder: Which antibodies, vaccines will hold up?
4 years ago
Moderna loses latest battle in key vaccine delivery patent fight as federal appeal falls flat
4 years ago
Covid-19 roundup: Old test samples suggest Omicron has been in Europe for weeks; US to tighten travel restrictions — report
4 years ago
'Don't freak out': Ugur Sahin takes a different tone on Omicron than his mRNA counterpart — reports
4 years ago
FDA adcomm narrowly votes in favor of Merck's antiviral for outpatient Covid-19
4 years ago
FDA+
Covid-19 roundup: Aspen to produce generic J&J vaccine for Africa; First boosters for under-18-year-olds could come next week — report
4 years ago
Like the flu vaccine every year, the FDA could move quickly on a variant-targeted Covid vaccine
4 years ago
FDA+
Ocugen hits another snag in bringing its Bharat Biotech-partnered Covid-19 vaccine to the US
4 years ago
FDA+
Covid-19 roundup: As Omicron spreads, African biotech reportedly close to reproducing Moderna's vaccine, while WHO creates pandemic prevention body
4 years ago
Omicron: Researchers scramble as new coronavirus mutation takes flight around the globe — Pfizer/BioNTech, Moderna vow swift response
4 years ago
Covid-19 roundup: Pfizer sues former employee for stealing vaccine secrets; European officials recommend vaccine boosters ahead of winter surge
4 years ago
Europe changes its tune on Covid-19 vaccine IP, advocating now for a 'targeted waiver'
4 years ago
Pharma
$107B in 2+ years? Pfizer’s Covid-19 vaccine may redefine ‘megablockbuster’ by 2022 — analyst
4 years ago
Pharma
Covid-19 roundup: WHO looks to boost production of antibody tests in lower-income countries; US government fights to uphold workplace vaccine mandate
4 years ago
Did Europe blunder in its Covid vaccine picks? Pascal Soriot points to a potential mistake — and jabs back over delays
4 years ago
New Pfizer/BioNTech Covid vaccine data in teens show strong protection, lining up sBLA filing
4 years ago
FDA+
Covid-19 roundup: Ahead of FDA, EU signs off on Merck's antiviral; Distribution of mAbs in US see first uptick in 7 weeks
4 years ago
FDA authorizes mRNA boosters from Pfizer, Moderna for all adults 6 months after vaccination
4 years ago
Covid-19 roundup: Pfizer lands massive $5B+ deal with US for potential pill; Boosters for all adults are incoming
4 years ago
First page
Previous page
16
17
18
19
20
21
22
Next page
Last page